CD38 and neoplasm: A representative example of one of these three independent experiments is shown in Figure 5B. Taken together, the combination of anti-mCD38 and anti-mPD-1 antibodies showed superior efficacy to either agent alone in mouse tumor models that express CD38 on tumor cells (both J558 and MC38), even when no single-agent antitumor activity was observed.